To use Oracle BIEE, please enable javascript in your browser.
Printer ImagePrintPrint Right Arrow Image
Excel ImageExport to ExcelPrint Right Arrow Image
Refresh ImageRefresh
 Create Prompted Link
 Clear My Customization
 
 
Default Layout
 
 
Edit Layouts...
Remove Layouts
New Layouts...
 
 
Export Current Page
Export Entire Dashboard
 
 
Loading
 
 
The number of individual cases identified in EudraVigilance for COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19) is 332,433 (up to 17/07/2021)

Number of individual cases by Age Group

 
 
 
 
Age Group
Cases
%
Not Specified 24,983 7.5%
0-1 Month 223 0.1%
2 Months - 2 Years 339 0.1%
3-11 Years 268 0.1%
12-17 Years 203 0.1%
18-64 Years 259,377 78.0%
65-85 Years 44,551 13.4%
More than 85 Years 2,489 0.7%
Total 332,433 100.0%

Number of individual cases by Sex

 
 
 
 
Sex
Cases
%
Female 239,683 72.1%
Male 84,411 25.4%
Not Specified 8,339 2.5%
Total 332,433 100.0%

Number of individual cases by Geographic Origin (EEA/Non-EEA)

 
 
 
 
Occurrence Country EEA/Non EEA
Cases
%
European Economic Area 163,094 49.1%
Non European Economic Area 169,339 50.9%
Not Specified 0  
Total 332,433 100.0%

Number of individual cases by Reporter Group

 
 
 
 
Reporter Group
Cases
%
Healthcare Professional 81,718 24.6%
Non Healthcare Professional 250,715 75.4%
Not Specified 0  
Total 332,433 100.0%
For the interpretation of the results, please refer to the key considerations at www.adrreports.eu